| 发明名称 |
MEDICINAL COMPOSITION |
| 摘要 |
<p>The present invention provides a pharmaceutical composition comprising N-(3-chloro-4-morpholin-4-yl)phenyl-N'-hydroxyimidoformamidine and sulfobutyl ether beta -cyclodextrin or a salt thereof, wherein sulfobutyl ether beta -cyclodextrin increases the solubility of N-(3-chloro-4-morpholin-4-yl)phenyl-N'-hydroxyimidoformamidine and improves the stability over time and over heat and light exposure.</p> |
| 申请公布号 |
EP1508332(A1) |
申请公布日期 |
2005.02.23 |
| 申请号 |
EP20030730639 |
申请日期 |
2003.05.27 |
| 申请人 |
TAISHO PHARMACEUTICAL CO., LTD |
发明人 |
ITO, SHUSEI;MIWA, AKIO;NAKANO, MARI |
| 分类号 |
A61K9/00;A61K9/19;A61K31/5375;A61K31/724;A61K47/40;A61P9/10;A61P43/00;(IPC1-7):A61K31/537;A61K9/08;A61K47/20 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
